Ignite Creation Date:
2025-12-24 @ 12:22 PM
Ignite Modification Date:
2025-12-24 @ 12:22 PM
Study NCT ID:
NCT04097561
Status:
RECRUITING
Last Update Posted:
2025-08-14
First Post:
2019-09-19
Is Possible Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Safety of Belimumab in People With Idiopathic CD4 Lymphopenia and Autoantibodies (Phoebe)
Sponsor:
National Institute of Allergy and Infectious Diseases (NIAID)
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-01-13
Start Date Type:
ACTUAL
Primary Completion Date:
2025-12-29
Primary Completion Date Type:
ESTIMATED
Completion Date:
2025-12-29
Completion Date Type:
ESTIMATED
First Submit Date:
2019-09-19
First Submit QC Date:
None
Study First Post Date:
2019-09-20
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-08-13
Last Update Post Date:
2025-08-14
Last Update Post Date Type:
ACTUAL